CVS Health stock
Price history
+10.00% over the period1 year: from $78.41 (November 17, 2025) to $86.25 (November 17, 2026), +10.00%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $86.25 |
| October 30, 2026 | $90.25 |
| September 30, 2026 | $85.69 |
| August 31, 2026 | $93.91 |
| July 31, 2026 | $104.43 |
| June 30, 2026 | $103.45 |
| May 29, 2026 | $90.98 |
| April 30, 2026 | $83.29 |
| March 31, 2026 | $71.82 |
| February 27, 2026 | $79.90 |
| January 30, 2026 | $74.52 |
| December 31, 2025 | $79.36 |
| November 28, 2025 | $80.36 |
| November 17, 2025 | $78.41 |
At a glance
The company
Operates a health care ecosystem encompassing health insurance, pharmacy benefit management, and retail pharmacy services
Latest results
Quarter to September 30, 2026 · EPS $2.09 (estimate $1.65)
TickerLandia's take on CVS Health
- Pricier than usual relative to earnings: P/E on the latest fiscal year 62 vs a median of 15 over its last 9 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 10 vs 19 (−45%) in a group of 7.
- Strong point: Dividend (75/100 in its group). Weak point: Financial strength (21/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−22.47% from the 52-week high
Analysts · 28 analysts
Average target$109.31+27.38% vs. price
Buy 25 · Hold 3 · Sell 0 · Strong buy
TickerLandia Fingerprint: CVS Health
Compared with similar companies: very low price.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery low15
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 10.4 9 Forward P/E 10.2 13 Price/book 1.41 11 Price/sales 0.27 13 EV/EBITDA 10.1 30 Profitabilitylow31
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 3.1% 26 Gross margin 13.7% 24 Net margin 2.6% 35 ROE 14.4% 57 ROA 3.1% 15 Earnings stabilityaverage57
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.3% 56 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthlow33
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +5.40% 38 Average revenue growth (3 years) +7.63% 28 Financial strengthlow21
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 4.89 9 Current ratio 0.85 22 Interest coverage 3.21 21 Debt/equitycounts in reverse: lower means more financial strength 0.93 34 Dividendhigh75
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 95 Dividend yield 3.0% 84 Payout ratio 31.1% 47 Market momentumweak36
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −4.68% 35 Relative strength (6 months) −10.61% 25 1-year return +9.44% 46 Distance from 200-day average −3.90% 37 Riskaverage41
How much the price swings.
Metric Value Position in group Volatility (60 days) 38.8% 61 Beta (1 year) −0.02 15 Maximum drawdown (12 months) 27.7% 47
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
CVS Health is pricier than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), CVS Health's P/E today is 62.1, above the median of its last 9 fiscal years (14.6; between 11.3 and 57.1 from 2016 to 2025). CVS Health's P/E (trailing 12 months): 10.4, −45% against the median of a group of 7 similar companies (18.9).
Compared with 7 similar companies
| Metric | CVS Health | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 10.4 | Low | |
| Forward P/E | 10.2 | Middle | |
| Operating margin | 3.1% | Middle | |
| ROE | 14.4% | Middle | |
| Debt/equity | 0.93 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: CVS Health. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$107.75B
Latest quarter · Q3 2026
Net income
$2.17B
Latest quarter · Q3 2026
Quarterly net margin
2.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $113.35B
- P/E
- 10.4
- EPS
- $8.54
- Volume
- 11.36M
- Daily trading
- €924.06M
- Dividend yield
- 3.10%
- Last ex-dividend on October 22, 2026
How CVS Health is changing
All resultsRevenue grew 8.4% a year on average over the last 5 years
Operating margin fell from 2.5% to 1.2%
Profits turn into cash: free cash flow equal to 167% of net income
Returns
CVS Health returns with dividends
$1,000 invested in CVS Health 5 years ago, on November 17, 2021, would be worth $1,099 today with dividends reinvested: +9.85% in total, +1.90% per year. On price alone it would be $930 (−6.99%).
| Period | CVS Health | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −6.94% | −3.17% | $931 |
| 6 months | −10.51% | +0.11% | $895 |
| Year to date | +8.68% | +8.34% | $1,087 |
| 1 year | +13.31% | +11.15% | $1,133 |
| 3 years | +40.23% | +64.30% | $1,402 |
| 5 years | +9.85% | +58.18% | $1,099 |
| 10 years | +58.36% | +239.10% | $1,584 |
Over the last 6 months it has done better than 12% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
CVS Health: technical analysis
CVS Health shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 24.4% below its highest close since January 2, 1990 ($113.45, July 29, 2015).
- Trend
- No clear trend
- RSI (14 sessions)
- 44
- Between 30 and 70
- vs 200-session average
- −3.90%
Active signals
Death cross: the 50-session average has crossed below the 200-session average.
The last session opened more than 3% below the previous close.
Support and resistance
Price areas where CVS Health has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$98.15+14.38%3 touches, last on September 2, 2026
- Resistance$92.68+8.01%2 touches, last on August 21, 2026
- Resistance$89.72+4.56%2 touches, last on September 28, 2026
- Last price$85.81
- Support$84.12−1.98%2 touches, last on October 1, 2026
- Support$80.82−5.82%6 touches, last on April 9, 2026
- Support$77.13−10.12%4 touches, last on November 4, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- −0.02
- Volatility (60 sessions, annualised)
- 38.8%
- Largest fall in the last year
- −27.70%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
CVS Health: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for CVS Health has been November: +2.89% on average, positive in 22 years out of 36. The weakest has been October: −1.14% on average, positive in 17 years out of 37.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.16% | −0.43% | 16 of 36 |
| February | +1.52% | +2.05% | 22 of 37 |
| March | +2.18% | +1.94% | 21 of 37 |
| April | +1.63% | +0.79% | 20 of 37 |
| May | +0.71% | +0.64% | 19 of 37 |
| June | −0.39% | −0.53% | 17 of 37 |
| July | +0.83% | +0.72% | 19 of 37 |
| August | −0.80% | +0.27% | 19 of 37 |
| September | +0.40% | −1.77% | 17 of 37 |
| October | −1.14% | −1.16% | 17 of 37 |
| November | +2.89% | +3.64% | 22 of 36 |
| December | +1.22% | +0.54% | 19 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
CVS Health and its competitors
With 219,000 employees, CVS Health Corporation combines health insurance, pharmacy benefit management and retail pharmacy in the United States. Its health insurance arm offers medical, pharmacy, dental and behavioral health plans, along with Medicare Advantage, Medicare Supplement and prescription drug plans and Medicaid management services, to employers, individuals, students, governments and labor groups. The pharmacy benefit management unit serves employers, insurers, unions and Medicaid managed care plans with formulary management, specialty and mail-order pharmacy, and disease management.
- Headquarters
- Woonsocket, United States
- Employees
- 219,000
- Founded
- 1963
- Chief executive
- J. Joyner
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| CVS HealthCVS | $113.35B | 3.1% | 10.4 | −10.51% |
| Elevance HealthELV | $96.04B | 4.0% | 18.9 | +10.50% |
| Cigna GroupCI | $77.95B | 3.9% | 12.2 | +3.08% |
| HumanaHUM | $50.12B | 2.3% | 39.0 | +45.30% |
| UnitedHealth GroupUNH | $369.18B | 5.9% | 23.5 | −1.06% |
| CenteneCNC | $33.52B | 1.9% | 22.8 | +24.51% |
Same industry or related industries, similar size. Compare CVS Health with its competitors · Full profile
